NEU 6.41% $15.27 neuren pharmaceuticals limited

Ann: Trofinetide successful in Phase 2 trial in Fragile X, page-70

  1. 117 Posts.
    lightbulb Created with Sketch. 64
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.